Pharming (PHAR) Equity Income (2020 - 2026)
Pharming's Equity Income was -$168,000 in Q2 2026, compared with -$429,000 a year earlier.
Powered by 
Analysis
Pharming (PHAR) Equity Income (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Pharming's Equity Income was -$4.37 million through Jun 30, 2026; for FY2025, it was $623,000.
- Equity Income shows a five-year compound annual growth rate of 11.5% (FY2020 to FY2025).
- In earlier years, Equity Income was -$1.76 million in FY2024, -$289,000 in FY2023, -$1.08 million in FY2022 and $694,000 in FY2021 (+91.7%).
- The Q2 2026 figure marks the highest quarterly Equity Income since Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | - |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | -2.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | -10.00 Mn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | - |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Pharming | 664.67 Mn | -129.70 Mn | 141.47 Mn | -168,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -168,000.00 |
| Mar 31, 2026 | -385,000.00 |
| Dec 31, 2025 | 1.35 Mn |
| Sep 30, 2025 | -52,000.00 |
| Jun 30, 2025 | -429,000.00 |
| Mar 31, 2025 | -250,000.00 |
| Dec 31, 2024 | -500,000.00 |
| Sep 30, 2024 | -442,000.00 |
| Jun 30, 2024 | 834,000.00 |
| Mar 31, 2024 | -500,000.00 |
| Dec 31, 2023 | 700,000.00 |
| Sep 30, 2023 | -485,000.00 |
| Jun 30, 2023 | 469,000.00 |
| Mar 31, 2023 | -339,000.00 |
| Dec 31, 2022 | 441,000.00 |
| Sep 30, 2022 | -100,000.00 |
| Dec 31, 2021 | -82,000.00 |
| Sep 30, 2021 | -125,004.46 |
| Dec 31, 2020 | 610,452.40 |
| Sep 30, 2020 | -86,437.72 |
API Access
Pharming Equity Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=equity-income&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "equity-income", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=equity-income&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();